The Association Between Parathyroid Hormone and Preterm Labor

NCT ID: NCT05688007

Last Updated: 2023-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-01

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study aims to test the level of parathyroid hormone in pregnant women. The main question it aims to answer is:

n Pregnant women, are the levels of serum PTH, calcium, magnesium, phosphorus \& albumin similar in both preterm and term births?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Approval from ethical committee will be sought.
* Patients will be enrolled from Ain Shams University Maternity Hospital labor ward and antenatal outpatient clinic.
* History, examination and fetal ultrasound will be done to identify eligible patients.

History: a full detailed history including personal, menstrual, obstetric, present, past history and family history will be obtained.

Accurate last menstrual period date will be obtained, and gestational age will be calculated using Naegele's rule or first trimester ultrasound to identify preterm patients with gestational age (28-36 weeks).

Examination: general, abdominal and vaginal examination to identify patients in established labor with Regular uterine contractions are at least 3 in 10 min each lasting 40 seconds. Progressive cervical dilatation (at least 4 cm). Ultrasound: for (viability of fetus, fetal biometry and estimated fetal weight, amniotic fluid, placental localization).

Thus, two groups of patients will be identified:

1. Cases: established preterm labor - gestational age: (28-36 weeks)
2. Controls: pregnant women not in labor - gestational age: (28- 36 weeks)

* Venous blood samples will be withdrawn about (3ml) once from every patient within one hour from inclusion into the study to measure serum parathyroid hormone, calcium, magnesium, phosphorus and albumin levels.
* Samples will not be collected from an arm with an intravenous catheter if alternate sites are available.
* Patient collection site will be appropriately disinfected prior to sample collection.
* After collection, samples will be put in a red or yellow tube (serum separating tube) with a serum gel separator.
* Samples will be gently mixed immediately following collection into tube to ensure proper preservation of the analytes. 180° tube inversion, allowing bubble to travel the length of the tube, followed by return to upright position is one mix.
* Samples will be delivered to laboratory within 30 to 60 minutes.
* Data will be collected and recorded in a case report form (Age, parity, previous preterm births/ miscarriage, gestational age, measured levels of serum PTH, calcium, magnesium, phosphorus \& albumin , mode of delivery, birth weight).
* Statistical analysis will be done to get results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Labor Parathyroid Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases

pregnant women with established preterm labor - gestational age: (28-36 weeks), having: Regular uterine contractions are at least 3 in 10 min each lasting 40 seconds. Progressive cervical dilatation (at least 4 cm).

parathyroid hormone level

Intervention Type DIAGNOSTIC_TEST

Serum level of parathyroid hormone

serum electrolytes

Intervention Type DIAGNOSTIC_TEST

Serum levels of: magnesium, phosphorus, calcium, and albumin

Controls

pregnant women not in labor - gestational age: (28- 36 weeks)

parathyroid hormone level

Intervention Type DIAGNOSTIC_TEST

Serum level of parathyroid hormone

serum electrolytes

Intervention Type DIAGNOSTIC_TEST

Serum levels of: magnesium, phosphorus, calcium, and albumin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

parathyroid hormone level

Serum level of parathyroid hormone

Intervention Type DIAGNOSTIC_TEST

serum electrolytes

Serum levels of: magnesium, phosphorus, calcium, and albumin

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women aged (18-40).
* Gestational age (28-36 weeks).

Exclusion Criteria

* Known maternal disease as diabetes, hypertension, renal disease, cardiac disease and liver disease.
* Known hypo or hyperparathyroidism
* Multiple pregnancy
* Polyhydramnios
* Premature rupture of membrane
* Antepartum Hemorrhage
* Uterine malformations e.g. bicornuate uterus
* Smoking
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams Maternity Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rania Hassan Mostafa

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sherif A Ashoush, MD

Role: STUDY_DIRECTOR

Faculty of Medicine Ain Shams University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams Maternity Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MS 168/2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.